Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer

Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer

Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors are efficacious in treating platinum-sensitive ovarian cancer (OC), but demonstrate limited efficiency in patients with platinum-resistant OC. Thus, further investigations into combined strategies that enhance the response to PARP inhibitors (P...

Full description

Bibliographic Details
Main Authors:	Sangsang Tang, Yuanming Shen, Xinyi Wei, Zhangjin Shen, Weiguo Lu, Junfen Xu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-09-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-022-05257-y

Similar Items

Arsenic compound sensitizes homologous recombination proficient ovarian cancer to PARP inhibitors
by: Junfen Xu, et al.
Published: (2021-09-01)

Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
by: S V Khokhlova
Published: (2017-09-01)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
by: Jonathan A. Ledermann, et al.
Published: (2019-05-01)

Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer
by: Qian Chen, et al.
Published: (2022-03-01)

Arsenic trioxide induces ferroptosis in neuroblastoma by mediating GPX4 transcriptional inhibition
by: Mingwei Su, et al.
Published: (2024-01-01)

Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences
by: Yuanming Shen, et al.
Published: (2022-03-01)

Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer
by: Yangyang Li, et al.
Published: (2023-01-01)

Synergic role of platinum (Pt) and molybdenum trioxide (MoO3) promoted HBEA zeolite towards n-heptane isomerization
by: L. P., Teh, et al.
Published: (2021)

Synergic role of platinum (Pt) and molybdenum trioxide (MoO3) promoted HBEA zeolite towards n-heptane isomerization
by: Teh, L. P., et al.
Published: (2021)

Randomised phase II trial of olaparib, chemotherapy, or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
by: Mansouri, A, et al.
Published: (2021)

Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation
by: Dinh Hoa Hoang, et al.
Published: (2022-06-01)

Honokiol attenuate the arsenic trioxide‐induced cardiotoxicity by reducing the myocardial apoptosis
by: An‐Liang Huang, et al.
Published: (2022-04-01)

Decitabine combined with arsenic trioxide inhibits proliferation and promotes apoptosis of acute myeloid leukemia cell lines
by: LIU Yue, CAO Yang, GU Weiying, SHANG Limei, LIU Yan
Published: (2023-04-01)

Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01)

Olaparib in the management of ovarian cancer
by: Bixel K, et al.
Published: (2015-08-01)

Response to arsenic trioxide in dental treatment
by: Chen Gin
Published: (2013-06-01)

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
by: Ting Hong, et al.
Published: (2021-06-01)

Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
by: Juan Yi, et al.
Published: (2022-10-01)

Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
by: Li-Li Song, et al.
Published: (2014-01-01)

Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
by: Degang Kong, et al.
Published: (2020-01-01)

Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide via Promoting Reactive Oxygen Species-Dependent Apoptosis and Pyroptosis
by: Wei Tian, et al.
Published: (2020-02-01)

Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques
by: Yizi He, et al.
Published: (2023-10-01)

Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
by: Yedjou Clement, et al.
Published: (2010-08-01)

Genistein Ameliorates Adverse Cardiac Effects Induced by Arsenic Trioxide Through Preventing Cardiomyocytes Apoptosis
by: Yuhua Fan, et al.
Published: (2013-01-01)

Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?
by: Atousa Haghi, et al.
Published: (2020-10-01)

Arsenic Trioxide And Thalidomide Combination Induces Autophagy Along With Apoptosis In Acute Myeloid Cell Lines
by: Mahnaz Mohammadi Kian, et al.
Published: (2020-07-01)

Arsenic trioxide as an inducer of immunogenic cell death
by: Oliver Kepp, et al.
Published: (2023-12-01)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
by: Yacong Li, et al.
Published: (2022-12-01)

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
by: Fang Zheng, et al.
Published: (2023-11-01)

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
by: Patrycja Gralewska, et al.
Published: (2021-09-01)

Profile of olaparib in the treatment of advanced ovarian cancer
by: Chase DM, et al.
Published: (2016-04-01)

Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
by: Yuni Wu, et al.
Published: (2012-03-01)

Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
by: Yuni Wu, et al.
Published: (2012-03-01)

Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
by: Tássia S. Tavares, et al.
Published: (2020-10-01)

Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
by: Shuping Wang, et al.
Published: (2015-01-01)

Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
by: Xiao-Yan Zhao, et al.
Published: (2014-01-01)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01)

Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.
by: Yayoi Yoshimura, et al.
Published: (2015-01-01)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
by: Peng Zhang
Published: (2017-01-01)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
by: Bodhisattwa Mondal, et al.
Published: (2018-05-01)